{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:55:32Z","timestamp":1793411732375,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.103850","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:56Z","timestamp":1786114976000},"page":"103850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["DNMT1-mediated silencing of SFRP1 promotes endometrial carcinogenesis through the Wnt\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"104","author":[{"given":"Chunyang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103850_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020445","article-title":"Epigenetics of SFRP1: The Dual Roles in Human Cancers","volume":"12","author":"Baharudin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.103850_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/epi.12.13","article-title":"Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice","volume":"4","author":"Banno","year":"2012","journal-title":"Epigenomics"},{"key":"10.1016\/j.tice.2026.103850_bib3","first-page":"526","article-title":"Endometrial Cancer: Rapid Evidence Review","volume":"111","author":"Bryce","year":"2025","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.tice.2026.103850_bib4","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.2174\/0929867328666210705144456","article-title":"Endometrial Cancer: Genetic, Metabolic Characteristics, Therapeutic Strategies and Nanomedicine","volume":"28","author":"Cai","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tice.2026.103850_bib5","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.21873\/anticanres.10984","article-title":"DNA Methylation Machinery in the Endometrium and Endometrial Cancer","volume":"36","author":"Caplakova","year":"2016","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.tice.2026.103850_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/cns.14100","article-title":"Marsdenia tenacissima extract prevents the malignant progression of glioma through upregulating lncRNA MEG3 and SFRP1-dependent inhibition of Wnt\/\u03b2-catenin pathway","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tice.2026.103850_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.21037\/tcr.2019.12.79","article-title":"MicorRNA-148b inhibits cell proliferation and facilitates cell apoptosis by regulating DNA Methyltransferase 1 in endometrial cancer","volume":"9","author":"Chen","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.tice.2026.103850_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ygyno.2008.10.026","article-title":"SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway","volume":"112","author":"Chung","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tice.2026.103850_bib9","first-page":"12168","article-title":"Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis","volume":"13","author":"De","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.tice.2026.103850_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.4160","article-title":"Alterations in Wnt-\u03b2-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression","volume":"230","author":"van der Zee","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.tice.2026.103850_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cbt.12.5.15963","article-title":"Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization","volume":"12","author":"Di Domenico","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tice.2026.103850_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12935-019-0751-z","article-title":"MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1\/Wnt pathway","volume":"19","author":"Hu","year":"2019","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.tice.2026.103850_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tice.2026.103850_bib14","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1242\/jcs.00623","article-title":"Secreted antagonists of the Wnt signalling pathway","volume":"116","author":"Kawano","year":"2003","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.tice.2026.103850_bib15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00432-009-0613-5","article-title":"Methylation analysis of SFRP genes family in cervical adenocarcinoma","volume":"135","author":"Lin","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103850_bib16","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.7150\/thno.111625","article-title":"FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.tice.2026.103850_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3557","article-title":"GRIK1-AS1 deficiency accelerates endometriosis progression by boosting DNMT1-dependent SFRP1 promoter methylation in endometrial stromal cells","volume":"25","author":"Liu","year":"2023","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tice.2026.103850_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tice.2026.103850_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40661-017-0056-7","article-title":"New therapies for advanced, recurrent, and metastatic endometrial cancers","volume":"4","author":"Makker","year":"2017","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.tice.2026.103850_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01326-2023","article-title":"Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts","volume":"63","author":"Mayr","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.tice.2026.103850_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/leu.2013.184","article-title":"Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention","volume":"28","author":"McCubrey","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.tice.2026.103850_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.soncn.2019.02.002","article-title":"Endometrial Cancer: An Overview of Pathophysiology, Management, and Care","volume":"35","author":"Passarello","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.tice.2026.103850_bib23","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.ejca.2013.07.011","article-title":"High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer","volume":"49","author":"Qu","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tice.2026.103850_bib24","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2217\/fon-2018-0564","article-title":"Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer","volume":"15","author":"Sch\u00e4fer","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.tice.2026.103850_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-13-156","article-title":"Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens","volume":"13","author":"Schirmer","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tice.2026.103850_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ijc.22750","article-title":"SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway","volume":"121","author":"Shih","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2026.103850_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/cncr.22023","article-title":"Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma","volume":"107","author":"Shih","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.tice.2026.103850_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1349-7006.2004.tb03255.x","article-title":"Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers","volume":"95","author":"Takada","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tice.2026.103850_bib29","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-09-0814","article-title":"Progesterone inhibition of Wnt\/beta-catenin signaling in normal endometrium and endometrial cancer","volume":"15","author":"Wang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.103850_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070938","article-title":"Research Progress of DNA Methylation in Endometrial Cancer","volume":"12","author":"Xu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.tice.2026.103850_bib31","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e71","article-title":"Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis","volume":"34","author":"Yi","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.tice.2026.103850_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tice.2026.103850_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13743","article-title":"WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt\/\u03b2-catenin signaling pathway","volume":"90","author":"Zhang","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.tice.2026.103850_bib34","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2019_2757","article-title":"SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt\/beta-catenin signaling","author":"Zhang","year":"2019","journal-title":"Acta Biochim. Pol. 66 393-400"},{"key":"10.1016\/j.tice.2026.103850_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626005446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:06:13Z","timestamp":1787457973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":35,"alternative-id":["S0040816626005446"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103850","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNMT1-mediated silencing of SFRP1 promotes endometrial carcinogenesis through the Wnt\/\u03b2-catenin pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103850"}}